press-releases
Lunaphore to present new data at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Date
LAUSANNE, Switzerland – October 13, 2022 – 5:00 PM (CEST) – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced it will share several presentations demonstrating the versatile capabilities of the company’s spatial biology technologies at The Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting, taking place virtually and in Boston, Mass. November 8 – 12, 2022. The company will present a recent study showing new hyperplex data on delicate samples. In addition, data on automated multi-omics analysis for mapping the tumor microenvironment (TME); and data on signal amplification strategies as an alternative method for detecting low-expressed markers, will be presented as well.
Additional partner posters will highlight how research institutions are using COMET™ to map the TME of colorectal and lung cancer and LabSat® to develop a test to predict whether patients with metastatic melanoma would respond to a certain combination of immunotherapies.
COMET™ is a high-throughput staining and imaging platform for hyperplex immunofluorescence. The system performs spatial biology analysis on tissue samples using standard, non-conjugated antibodies and enables simultaneous analysis of 40 different spatial markers per tissue slide without user intervention. Leveraging Lunaphore’s sequential immunofluorescence (seqIF™) approach, COMET™ allows unmatched reproducibility, producing robust, high-quality data. LabSat® is a compact and open automated tissue staining instrument for immunohistochemistry and immunofluorescence, a unique solution designed to address spatial biology hurdles with one platform.
Lunaphore poster presentation details
Signal amplification strategies for in situ detection of low-expressed markers in multiplex immunofluorescence
Poster #: 37
Date & Time: November 10, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Pino Bordignon, Team Leader Application Research, Lunaphore
Fully automated spatial multi-omics analysis to map the tumor microenvironment with single-cell resolution
Poster #: 38
Date & Time: November 11, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Pino Bordignon, Team Leader Application Research, Lunaphore
Mapping the tissue composition with hyperplex immunofluorescence on delicate samples
Poster #: 78
Date & Time: November 11, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Joanna Kowal, Team Leader Application Development, Lunaphore
Lung cancer partner poster presentation details
Mapping the tumor microenvironment with sequential immunofluorescence, an automated image analysis pipeline, and spatial metrics
Poster #: 85
Date & Time: November 10, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Joanna Kowal, Team Leader Application Development, Lunaphore
Research conducted in collaboration with Visiopharm
Colorectal cancer collaboration poster presentation details
Mapping the heterogeneous colorectal microenvironment with multiplexed imaging and machine learning HUB-SIB InnoSuisse Grant
Poster #: 1275
Date & Time: November 10, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Joanna Kowal, Team Leader Application Development, Lunaphore
Research conducted in collaboration with the University Hospital of Geneva and the Swiss Institute of Bioinformatics
Characterization of tumor budding and the tumor microenvironment in colorectal cancer using hyperplex immunofluorescence
Poster #: 1459
Date & Time: November 10, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Cansaran Saygili Demir, Post-doctoral fellow, University of Bern
Research conducted in collaboration with Prof. Inti Zlobec, Director of Translational Research Unit (TRU) at the Institute of Pathology, University of Bern
Melanoma collaboration poster presentation details
Development of a multiplex test for predicting response to combined immunotherapies in patients with metastatic melanoma
Poster #: 842
Date & Time: November 11, 2022 | 11:55 AM – 1:25 PM and 7 – 8:30 PM EST
Speaker: Dr. Gabriele Madonna, Health Researcher, Department of Melanoma, National Cancer Institute
Research conducted in collaboration with Dr. Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy at the National Tumor Institute Fondazione G. Pascale in Naples
The posters are available during the conference opening times of the given day. Presenters will hold the reception at 11:55 AM – 1:25 PM and 7 – 8:30 PM EST.
Learn more about the event and book a meeting with Lunaphore here.
About Lunaphore
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next-generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com.
For further information contact:
Irene Tamayo
Lunaphore Corporate Communications
Email: [email protected]
